Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.02
-0.0400-1.94%
Post-market: 2.080.0600+2.97%16:43 EDT
Volume:1.55M
Turnover:3.09M
Market Cap:363.60M
PE:-18.25
High:2.05
Open:2.02
Low:1.93
Close:2.06
52wk High:3.04
52wk Low:0.3418
Shares:180.00M
Float Shares:112.00M
Volume Ratio:0.61
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1107
EPS(LYR):-0.1107
ROE:-5.98%
ROA:-3.26%
PB:2.29
PE(LYR):-18.25

Loading ...

Century Therapeutics Inc held special shareholder meeting

Reuters
·
Jan 26

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

TIPRANKS
·
Jan 24

Century Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 20

Century Therapeutics price target raised to $4 from $2 at Piper Sandler

TIPRANKS
·
Jan 20

Top Midday Gainers

MT Newswires Live
·
Jan 09

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

TIPRANKS
·
Jan 09

Century Therapeutics Shares Hit 52-Week High After Private Placement Deal

Dow Jones
·
Jan 08

BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813

Reuters
·
Jan 08

Century Therapeutics Inc - Financing Led by Tcgx With Multiple Investors Participating

THOMSON REUTERS
·
Jan 08

Press Release: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes

Dow Jones
·
Jan 08

Chief Scientific Officer Chad Cowan Reports Acquisition of Century Therapeutics Inc Common Shares

Reuters
·
Dec 30, 2025

Century Therapeutics Director Carlo Rizzuto Resigns

Reuters
·
Dec 30, 2025

3 Promising Penny Stocks With Market Caps Over $30M

Simply Wall St.
·
Dec 19, 2025

Century Therapeutics CEO Brent Pfeiffenberger Reports Acquisition of Common Shares

Reuters
·
Dec 17, 2025

Century Therapeutics Inc Files Initial Statement of Beneficial Ownership for Director Han Myung Lee

Reuters
·
Dec 12, 2025

Century Therapeutics Appoints Han Lee and Martin Murphy to Board

Reuters
·
Dec 09, 2025

Press Release: Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

Dow Jones
·
Dec 09, 2025

We're Keeping An Eye On Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate

Simply Wall St.
·
Nov 30, 2025

Century Therapeutics CEO Brent Pfeiffenberger Reports Acquisition of Common Shares

Reuters
·
Nov 21, 2025

Century Therapeutics CEO Makes Significant Stock Sale!

TIPRANKS
·
Nov 20, 2025